Polymyxins have suboptimal pharmacokinetic/pharmacodynamics properties, non-satisfactory therapeutic effects, toxicity, and an increasing trend of resistant bacteria [ 10 , 11 ].
← all excerpts
Ceftazidime-Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients.
1
—
—